[Short-term therapy of painful muscular disorders. Results of a multicenter double-blind test of 2 new suppository preparations with and without codeine].
A report is given about a multicentric double-blind test for proof of effectiveness of two new suppository preparations with and without codeine against comparable remedies. Dolo Visano Supp. sine codeino showed a slight superiority over the reference preparation. This was proved above all for the influence upon pain and muscular overstrain. The better tolerability was marked. Dolo Visano Supp. (with codeine) showed advantages against the reference preparation. It was used in cases of severe pain, and in 88% it had a very good effect, whereas for the reference preparation this applied only in 67,9%. The assessments of physician and patients were almost alike. The myotonolytic effect has been proved equally for both of the new suppository preparations.
D001168:Arthritis / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003061:Codeine / Q000627:therapeutic use*; D004155:Diphenhydramine / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D008620:Meprobamate / Q000627:therapeutic use*; D009127:Muscle Rigidity / Q000188:drug therapy; D009408:Nerve Compression Syndromes / Q000188:drug therapy*; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010003:Osteoarthritis / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D010936:Plant Extracts / Q000627:therapeutic use*; D012457:Salicylamides / Q000627:therapeutic use*; D012459:Salicylates / Q000627:therapeutic use*; D013126:Spinal Nerve Roots; D013488:Suppositories
D004338:Drug Combinations; D009539:Nicotinic Acids; D010936:Plant Extracts; D012457:Salicylamides; D012459:Salicylates; D013488:Suppositories; C020305:dolo visano; C029072:benzyl pyridine-3-carboxylate, camphor, capsici extract, diethylammonium salicylate, dolo visano, salicylamide drug combination.; D004155:Diphenhydramine; D008620:Meprobamate; D001241:Aspirin; D003061:Codeine
Kurzzeittherapie schmerzhafter muskulärer Beschwerden. Ergebnis einer multizentrischen Doppelblind-Prüfung von 2 neuen Zäpfchen-Präparaten mit und ohne Kodein.